Shillong, June 15: Samsung Electronics has announced the expansion of the ‘Irregular Heart Rhythm Notification’ (IHRN) feature on the Samsung Health Monitor app to 13 markets, starting this summer.
The company shared this news through a blog post on Wednesday, highlighting how the IHRN feature, combined with the app’s Electrocardiogram (ECG) monitoring, assists Galaxy Watch users in understanding their heart health better by detecting heart rhythms that may indicate atrial fibrillation (AFib).
The Korean Ministry of Food and Drug Safety (MFDS) recently approved this new feature, following its clearance by the US Food and Drug Administration (FDA). Samsung will introduce the IHRN feature in Argentina, Azerbaijan, Costa Rica, the Dominican Republic, Ecuador, Georgia, Guatemala, Hong Kong, Indonesia, Panama, the UAE, as well as Korea and the US, bringing the total number of markets to 13.
The IHRN feature continuously monitors for irregular heart rhythms in the background, in addition to the on-demand ECG tracking, and alerts users if suspected AFib activity is detected.
Hon Pak, Vice President and Head of the Digital Health Team, MXABusiness at Samsung Electronics, emphasized the company’s commitment to empowering users to stay informed about their heart health by providing monitoring tools. He stated, “Cardiovascular disease remains one of the main causes of death worldwide, and we’re committed to empowering our users to stay informed about their heart health by providing monitoring tools.”
With the expansion of the IHRN feature, Samsung aims to make heart health monitoring more accessible and convenient for users across multiple markets, contributing to the overall well-being of individuals.
